Introduction: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor. Despite technological achievements its prognosis remains dismal. Genetic analysis has recently emerged as a powerful research tool and has allowed the discovery of many genetic alterations found in this type of cancer. As a result, gene therapy has been proposed as a promising strategy for the treatment of GBM. Aim: We describe the differentiation of astrocytes from mouse embryonic stem cells (mESC) expressing the doxicicline inducible MDA-7/IL-24 transgene and document its anti-tumor effects in vitro and in vivo. Materials and Methods: Differentiation of astrocytes was obtained from MDA-7/IL-24 transgenic mESC and documented by morphological analysis and immonofluorescence techniques. Astrocytes were further studied to assess their ability to conditionally express the MDA-7/IL-24 transgene, to migrate towards tumor cells and to cause apoptosis in U87 human high grade glioma (HGG) cells. In vivo anti-GBM properties of transgenic astrocytes were studied in a murine orthotopic xenograft model. Results: Complete differentiation of astrocytes conditionally expressing the MDA-7/IL-24 transgene was obtained. They retained migration abilities and were able to induce apoptosis in U87 cells. A significant reduction of implanted tumor volumes was observed in vivo after treatment with astrocytes. Conclusions: ESC-derived astrocytes conditionally expressing MDA-7/IL-24 transgene show promising pro-apoptotic activity against U87 HGG cells both in vitro and in vivo. Due to the preliminary nature of our results further research is warranted to allow translation of the reported results into the clinic.

Differenziazione di astrociti da cellule staminali embrionali e loro uso come vettori di transgeni nella terapia sperimentale dei gliomi cerebrali(2011 Feb 21).

Differenziazione di astrociti da cellule staminali embrionali e loro uso come vettori di transgeni nella terapia sperimentale dei gliomi cerebrali

-
2011-02-21

Abstract

Introduction: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor. Despite technological achievements its prognosis remains dismal. Genetic analysis has recently emerged as a powerful research tool and has allowed the discovery of many genetic alterations found in this type of cancer. As a result, gene therapy has been proposed as a promising strategy for the treatment of GBM. Aim: We describe the differentiation of astrocytes from mouse embryonic stem cells (mESC) expressing the doxicicline inducible MDA-7/IL-24 transgene and document its anti-tumor effects in vitro and in vivo. Materials and Methods: Differentiation of astrocytes was obtained from MDA-7/IL-24 transgenic mESC and documented by morphological analysis and immonofluorescence techniques. Astrocytes were further studied to assess their ability to conditionally express the MDA-7/IL-24 transgene, to migrate towards tumor cells and to cause apoptosis in U87 human high grade glioma (HGG) cells. In vivo anti-GBM properties of transgenic astrocytes were studied in a murine orthotopic xenograft model. Results: Complete differentiation of astrocytes conditionally expressing the MDA-7/IL-24 transgene was obtained. They retained migration abilities and were able to induce apoptosis in U87 cells. A significant reduction of implanted tumor volumes was observed in vivo after treatment with astrocytes. Conclusions: ESC-derived astrocytes conditionally expressing MDA-7/IL-24 transgene show promising pro-apoptotic activity against U87 HGG cells both in vitro and in vivo. Due to the preliminary nature of our results further research is warranted to allow translation of the reported results into the clinic.
21-feb-2011
Glioblastoma; terapia genica; MDA-7/IL-24; astrociti transgenici; apoptosi
Carai, Andrea
Differenziazione di astrociti da cellule staminali embrionali e loro uso come vettori di transgeni nella terapia sperimentale dei gliomi cerebrali(2011 Feb 21).
File in questo prodotto:
File Dimensione Formato  
Carai_A_Differenziazione_di_astrociti_da.pdf

accesso aperto

Tipologia: Altro materiale allegato
Licenza: Non specificato
Dimensione 3.67 MB
Formato Adobe PDF
3.67 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/251126
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact